Found: 29
Select item for more details and to access through your institution.
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy).
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 4, p. 467, doi. 10.1007/s00262-010-0958-2
- By:
- Publication type:
- Article
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1297, doi. 10.1007/s00262-008-0642-y
- By:
- Publication type:
- Article
Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 9, doi. 10.1007/s00262-001-0249-z
- By:
- Publication type:
- Article
Methylation-regulated expression of HLA class I antigens in melanoma.
- Published in:
- International Journal of Cancer, 2003, v. 105, n. 3, p. 430, doi. 10.1002/ijc.11077
- By:
- Publication type:
- Article
Unbalanced expression of HLA-A and -B antigens: A specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-γ.
- Published in:
- International Journal of Cancer, 2001, v. 91, n. 4, p. 500, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1076>3.0.CO;2-I
- By:
- Publication type:
- Article
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6557, doi. 10.1038/sj.onc.1206813
- By:
- Publication type:
- Article
Epigenetic targets for immune intervention in human malignancies.
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6484, doi. 10.1038/sj.onc.1206956
- By:
- Publication type:
- Article
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6564, doi. 10.1038/sj.onc.1206960
- By:
- Publication type:
- Article
Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 4, p. 548, doi. 10.1002/ijc.2910610420
- By:
- Publication type:
- Article
Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-116
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications.
- Published in:
- Journal of Cellular Physiology, 2007, v. 212, n. 2, p. 330, doi. 10.1002/jcp.21066
- By:
- Publication type:
- Article
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications.
- Published in:
- Journal of Cellular Physiology, 2006, v. 207, n. 1, p. 58, doi. 10.1002/jcp.20540
- By:
- Publication type:
- Article
Methylation‐regulated expression of cancer testis antigens in primary effusion lymphoma: Immunotherapeutic implications L. Calabrò and E. Fonsatti contributed equally to this work.
- Published in:
- Journal of Cellular Physiology, 2005, v. 202, n. 2, p. 474, doi. 10.1002/jcp.20133
- By:
- Publication type:
- Article
Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma (This study is dedicated to the memory of Raffaele Tecce.).
- Published in:
- Journal of Cellular Physiology, 2004, v. 200, n. 2, p. 272, doi. 10.1002/jcp.20015
- By:
- Publication type:
- Article
Differential levels of soluble endoglin (CD105) in myeloid malignancies.
- Published in:
- Journal of Cellular Physiology, 2003, v. 194, n. 2, p. 171, doi. 10.1002/jcp.10200
- By:
- Publication type:
- Article
Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.
- Published in:
- Journal of Cellular Physiology, 2002, v. 190, n. 2, p. 200, doi. 10.1002/jcp.10050
- By:
- Publication type:
- Article
Endoglin: An accessory component of the TGF-β-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
- Published in:
- Journal of Cellular Physiology, 2001, v. 188, n. 1, p. 1, doi. 10.1002/jcp.1095
- By:
- Publication type:
- Article
Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement.
- Published in:
- Journal of Cellular Physiology, 2000, v. 185, n. 3, p. 317, doi. 10.1002/1097-4652(200012)185:3<317::AID-JCP1>3.0.CO;2-L
- By:
- Publication type:
- Article
The overlooked 'nonclassical' functions of major histocompatibility complex (MHC) class II antigens in immune and nonimmune cells.
- Published in:
- Journal of Cellular Physiology, 1999, v. 179, n. 3, p. 251, doi. 10.1002/(SICI)1097-4652(199906)179:3<251::AID-JCP2>3.0.CO;2-P
- By:
- Publication type:
- Article
Fourteenth Meeting of the <italic>Network Italiano per la Bioterapia dei Tumori (NIBIT)</italic> on Cancer Bio-Immunotherapy, Siena, Italy, October 13-15, 2016.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1021, doi. 10.1007/s00262-013-1418-6
- By:
- Publication type:
- Article
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 41, doi. 10.1007/s00262-011-1089-0
- By:
- Publication type:
- Article
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.
- Published in:
- Cardiovascular Research, 2010, v. 86, n. 1, p. 12, doi. 10.1093/cvr/cvp332
- By:
- Publication type:
- Article
Is it the primetime for endoglin (CD105) in the clinical setting?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.
- Published in:
- Journal of Cellular Physiology, 2010, v. 223, n. 2, p. 352, doi. 10.1002/jcp.22040
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-82
- By:
- Publication type:
- Article
Effects of Nitrendipine in Patients with Chronic Renal Failure.
- Published in:
- American Journal of Nephrology, 1986, v. 6, n. S1, p. 162, doi. 10.1159/000167242
- By:
- Publication type:
- Article